LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTIC

Title:

LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTIC

Document Type and Number:

Japanese Patent JP2021073170

Kind Code:

A

Abstract:

To provide compounds that target the lanthionine synthetase C-like protein 2 pathway.SOLUTION: The present invention provides a compound represented by the following formula. Q is, for example, piperazine-1,4-diyl, benzene-1,4-diamine-N1, N4-diyl or the like, A1 and A1' are N or CR6, A2 and A2' are N or CR7, A3 is NR8, O, or S, A4 is N or CR9, A5 is N or CR10, A6 is N or CR11, R1, R2, R3, R3', R4, R4', R5', R6, R7, R8, R9, R10, and R11 are hydrogen, alkyl or the like.SELECTED DRAWING: None

More Like This:

JPH08500585	[Title of Invention] A novel leukotriene-B bottom 4 -antagonist, its production method and its use as a medicine
JPS61502192	[Title of the Invention] Oral active heparin multiplex object
JP4633123	Method for producing isonicotinic acid derivative

Inventors:

JOSEP BASSAGANYA-RIERA
CARBO BARRIOS ADRIA
GANDOUR RICHARD
JULIAN D COOPER
RAQUEL HONTECILLAS

Application Number:

JP2020201503A

Publication Date:

May 13, 2021

Filing Date:

December 04, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

LANDOS BIOPHARMA INC

International Classes:

C07D213/79; C07C65/40; C07D235/18; C07D263/62; C07D307/68; C07D401/04; C07D401/14; C07D413/04; C07D413/14

Foreign References:

US20110027558A1

2011-02-03

Attorney, Agent or Firm:

Shinichiro Tanaka
▲吉▼田和彦
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori

Previous Patent: ＮＫ細胞におけるサイトカイン誘導性ＳＨ２タンパク質の阻害

Next Patent: （Ｒ）−ジミラセタム（１）と（Ｓ）−ジミラセタム（２）を非ラセミ比�...